BIOMAT Database Logo BIOMAT Database Logo

Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus. 1991

B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Department of Virology, Karolinska Institute, Stockholm, Sweden.

An acute infection with simian immunodeficiency virus (SIVSM) in cynomolgus monkeys was used to evaluate the antiviral effects of 3'-fluorothymidine (FLT) and 3'-azidothymidine [zidovudine (ZDV)]. Neither compound prevented the infection despite dosing prior to virus inoculation. FLT was about ten times more potent than ZDV in delaying the appearance of SIVSM antigen in the monkeys. The serum half-life of FLT was longer than that of ZDV and ZDV was bound to plasma proteins to about 60% while FLT was virtually unbound. It is proposed that the in vivo difference in potency between ZDV and FLT could, at least partly, be explained as the combined effects of a longer plasma half-life and a higher free concentration of FLT and possibly a higher intracellular concentration of the triphosphate of FLT.

UI MeSH Term Description Entries
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer

Related Publications

B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Long-term tolerance and efficacy of 3'-azidothymidine and 3'-fluorothymidine treatment of asymptomatic monkeys infected with simian immunodeficiency virus.
August 1992, Antimicrobial agents and chemotherapy,
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus.
December 1990, The American journal of pathology,
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeys.
February 1998, AIDS (London, England),
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Antiviral effects of 6-chloro-2',3'-dideoxyguanosine in rhesus monkeys acutely infected with simian immunodeficiency virus.
January 1998, Antiviral chemistry & chemotherapy,
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Phenotypic changes in peripheral blood monocytes of cynomolgus monkeys acutely infected with simian immunodeficiency virus.
September 1998, AIDS research and human retroviruses,
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Coreceptor usage of sequential isolates from cynomolgus monkeys experimentally Infected with simian immunodeficiency virus (SIVsm).
December 2001, Virology,
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Lymphoid follicles in cynomolgus monkeys after infection with simian immunodeficiency virus.
January 1993, Advances in experimental medicine and biology,
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus.
March 1992, AIDS (London, England),
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Thymus in simian immunodeficiency virus-infected rhesus monkeys.
October 1991, Laboratory investigation; a journal of technical methods and pathology,
B Lundgren, and D Böttiger, and E Ljungdahl-Ståhle, and E Norrby, and L Ståhle, and B Wahren, and B Oberg
Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus.
February 1999, Neuropathology and applied neurobiology,
Copied contents to your clipboard!